Skip to content
Healthcare Industry News, Trends & Articles

Press release

The Global Chronic Liver Diseases Therapeutics Market Is Projected to Grow at a 10.3% CAGR Over the Forecast Period

TBThe Business Research Company4 min read

Chronic Liver Diseases Therapeutics

Chronic Liver Diseases Therapeutics

The Business Research Company

The Business Research Company

The Business Research Company’s Chronic Liver Diseases Therapeutics Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 18, 2026 /EINPresswire.com/ -- The global landscape for chronic liver disease treatments is evolving rapidly as advancements in medical care and broader healthcare access drive market growth. Increasing awareness of liver conditions and innovations in therapy are shaping a promising future for this important segment of healthcare. Below is an overview of the market size, key drivers, regional outlook, and emerging trends within the chronic liver diseases therapeutics industry.

Chronic Liver Diseases Therapeutics Market Size and Growth Outlook
The market for chronic liver disease therapeutics has seen significant expansion in recent years. It is projected to rise from $15.88 billion in 2025 to $17.56 billion in 2026, representing a compound annual growth rate (CAGR) of 10.6%. This historic growth has been supported by better diagnosis of chronic liver ailments, wider use of antiviral drugs, more effective management of autoimmune liver diseases, enhanced access to hospital-based liver treatments, and the expansion of specialized hepatology services. Looking ahead, the market is expected to surge further, reaching $25.99 billion by 2030 with a CAGR of 10.3%. Factors fueling this future growth include increased investment in therapies targeting NASH and fibrosis, greater demand for precision liver medicine, advances in biologic and targeted drug development, a stronger focus on early intervention strategies, and heightened clinical trial activity related to liver diseases. Notable trends anticipated during this period involve the emergence of targeted liver therapies, disease-specific treatment approaches, broader use of combination drug regimens, expansion of non-invasive disease monitoring tools, and intensified efforts to slow disease progression.

Download a free sample of the chronic liver diseases therapeutics market report:
https://thebusinessresearchcompany.com/sample_request?id=50713403&type=smp&name=Chronic%20Liver%20Diseases%20Therapeutics%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Understanding Chronic Liver Disease Therapeutics
Chronic liver disease therapeutics encompass a range of medical treatments and interventions designed to manage long-term liver conditions. These approaches aim to decelerate disease advancement, relieve symptoms, and enhance liver function through the use of medications, lifestyle modifications, and sometimes specialized medical procedures.

Alcohol Consumption as a Significant Market Driver
One of the primary factors propelling the chronic liver disease therapeutics market is the rising consumption of alcohol worldwide. Alcohol intake, which includes moderate to heavy use of ethanol-containing beverages, has increased due to growing social acceptance, improved income levels, and easier availability. Treatments for chronic liver disease play a crucial role in addressing liver damage caused by excessive alcohol consumption by slowing disease progression and improving liver health. For example, in June 2024, the US financial institution First Citizens Bank reported a 1.2% rise in direct-to-consumer wine case sales in 2023 compared to the previous year. Additionally, a December 2023 report from Kirin Holdings Company Limited, a Japanese beverage firm, highlighted that beer consumption reached approximately 192.1 million kiloliters in 2022, marking a 2.9% increase from 2021. This upward trend in alcohol use is a key contributor to the growth of the chronic liver disease therapeutics market.

View the full chronic liver diseases therapeutics market report:
https://thebusinessresearchcompany.com/report/chronic-liver-diseases-therapeutics-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Additional Factors Supporting Market Expansion
Beyond alcohol consumption, other drivers include the widespread adoption of antiviral therapies, enhanced screening and diagnostic capabilities, and a growing emphasis on specialty liver care. These elements collectively boost demand for effective therapeutics designed to manage and treat chronic liver conditions, supporting sustained market momentum.

Regional Growth Dynamics Within the Chronic Liver Diseases Therapeutics Market
In 2025, North America held the largest share of the chronic liver diseases therapeutics market. The comprehensive market report covers multiple regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Among these, Asia-Pacific is anticipated to exhibit the fastest growth rate in the coming years, driven by increasing healthcare investments, rising prevalence of liver diseases, and expanding access to advanced therapeutics across the region.

What’s new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.